AJR Live Webinars feature leading experts discussing some of AJR’s most controversial, cutting-edge articles—broadcasted each month live, online, with CME.

Miss a broadcast? You can still watch Past AJR Live Webinars and earn credit.

The AJR Live Webinar Series was made possible in part by an unrestricted educational grant from Siemens Healthcare.

Upcoming Webinars

Automated Interpretation of Abdominal CT: Current Status and Future Prospects

July 17, 2019

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time
Moderator: Perry Pickhardt, MD
Speaker: Ron Summers, MD, PhD

This AJR Live Webinar offers 1 CME Credit.

ARRS Member Price: $0

ARRS In-Training Member Price: $0
Nonmember Price: $99

REGISTER NOW

This webinar will provide an overview of the current status and future prospects in CT-based automation and artificial intelligence. It will demonstrate the predictive value of quantitative CT-based biomarkers at assessing risk for adverse events like MI, stroke, fragility fracture, and death.

Learning Outcomes

After attending this session, participants will be able to:

  • Identify “practical AI” and how it will soon be used in clinical practice.
  • Explain how quantitative CT-based biomarkers have predictive value.

Prostate Cancer Theranosis: 68Ga PSMA PET/CT and 177Lu PSMA Therapy

August 21, 2019

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time
Moderator: Rathan Subramaniam, MD, PhD, MPH
Speaker: CS Bal, MD, and Ayse Tuba Kendi, MD

This AJR Live Webinar offers 1 CME Credit.

ARRS Member Price: $0

ARRS In-Training Member Price: $0
Nonmember Price: $99

REGISTER NOW

68Ga PET/CT and 177Lu PSMA therapy have been transforming the care of prostate cancer patients worldwide over the last few years and have been introduced in the United States under clinical research. The FDA approval for these theranostic modalities is expected in the near future.

This webinar will cover an overview of 68Ga PSMA PET/CT in imaging prostate cancer detection, staging and recurrence and 177Lu PSMA therapy in treating prostate cancer patients.

 

Learning Outcomes

After attending this session, participants will be able to:

  • Articulate the value of 68Ga PSMA PET/CT in imaging prostate cancer detection, staging and recurrence.
  • Articulate the value and impact of 177Lu PSMA therapy in treating prostate cancer patients.

 


The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

The ARRS designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.